Abrdn Life Sciences Investors (NYSE:HQL) Announces Dividend Increase – $0.50 Per Share

Abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Wednesday, November 13th,Wall Street Journal reports. Shareholders of record on Thursday, November 21st will be paid a dividend of 0.50 per share on Friday, January 10th. This represents a $2.00 annualized dividend and a yield of 13.87%. The ex-dividend date of this dividend is Thursday, November 21st. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49.

Abrdn Life Sciences Investors Stock Performance

Shares of Abrdn Life Sciences Investors stock opened at $14.42 on Friday. Abrdn Life Sciences Investors has a 1 year low of $11.62 and a 1 year high of $15.90. The firm’s 50-day simple moving average is $15.03 and its 200-day simple moving average is $14.64.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.